摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-苄基八氢-1H-吡啶并[1,2-a]吡嗪 | 36067-99-9

中文名称
2-苄基八氢-1H-吡啶并[1,2-a]吡嗪
中文别名
——
英文名称
2-Benzyl-octahydropyrido<1,2-a>pyrazin
英文别名
2-benzyl-octahydro-pyrido[1,2-a]pyrazine;2-benzyl-octahydro-1H-pyrido[1,2-a]pyrazine;2-Benzyloctahydro-1H-pyrido[1,2-a]pyrazine;2-benzyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine
2-苄基八氢-1H-吡啶并[1,2-a]吡嗪化学式
CAS
36067-99-9
化学式
C15H22N2
mdl
——
分子量
230.353
InChiKey
IKNPRYWTPFSTAT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    6.5
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090

SDS

SDS:7fa055ae6ae87ceb136c2a95220383a0
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-苄基八氢-1H-吡啶并[1,2-a]吡嗪 在 palladium on activated charcoal 盐酸氢气 作用下, 以 甲醇 为溶剂, 反应 4.0h, 以96%的产率得到octahydro-pyrido[1,2-a]pyrazine; dihydrochloride
    参考文献:
    名称:
    6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY
    摘要:
    本公开提供了具有亲和力的化合物,其对5-HT6受体具有亲和力,其化学式为(I): 其中R1-R4,A,B,D,E和G如本文所定义。该公开还涉及制备这种化合物的方法,含有这种化合物的组合物,以及这些化合物的使用方法。
    公开号:
    US20080200471A1
  • 作为产物:
    参考文献:
    名称:
    [EN] THERMALLY-CLEAVABLE PROTECTING AND LINKER GROUPS
    [FR] GROUPES PROTECTEURS ET DE LIAISON THERMIQUEMENT CLIVABLES
    摘要:
    本发明涉及化学连接剂和保护基团,含有化学连接剂或保护基团的化合物和组合物,以及可用于制备它们的中间体和过程。这些化学连接剂和保护基团基于吡咯烷和哌哆啶活化基团,加热后发生分子内环化,并释放二氧化碳,从而释放有机化合物从底物中。特别是,这些化学连接剂和保护基团在寡核苷酸的固相合成中具有用途,具体方案如下。
    公开号:
    WO2018189546A1
  • 作为试剂:
    描述:
    2-benzyl-hexahydro-6H-pyrido[1,2-a]pyrazine-1,4-dionesodium hydroxide 在 LiAlH 、 magnesium sulfate 、 ethyl acetate petroleum ether 、 2-苄基八氢-1H-吡啶并[1,2-a]吡嗪 作用下, 以 四氢呋喃 为溶剂, 反应 3.0h, 以This resulted in 60 g (70%) of 2-benzyl-octahydro-1H-pyrido[1,2-a]pyrazine as a yellow solid的产率得到2-苄基八氢-1H-吡啶并[1,2-a]吡嗪
    参考文献:
    名称:
    6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY
    摘要:
    本公开提供了具有5-HT6受体亲和力的化合物,其化学式为(I):其中R1-R4A、B、D、E和G的定义如本文所述。本公开还涉及制备这些化合物的方法、含有这些化合物的组合物以及使用这些化合物的方法。
    公开号:
    US20080200471A1
点击查看最新优质反应信息

文献信息

  • [EN] PIPERAZINE UREA DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS<br/>[FR] DERIVES D'UREE DE PIPERAZINE UTILISES COMME AGONISTES DES RECEPTEURS DE MELANOCORTINE-4
    申请人:MERCK & CO INC
    公开号:WO2004024720A1
    公开(公告)日:2004-03-25
    Certain novel piperazine urea derivatives are agonists of the human melanocortin-4 receptor (MC-4R) and, in particular, are receptor-subtype selective agonists of MC-4R. They are useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity and diabetes.
    某些新型哌嗪脲衍生物是人类黑色素皮质素-4受体(MC-4R)的激动剂,特别是MC-4R的受体亚型选择性激动剂。它们对于治疗、控制或预防对MC-4R激活敏感的疾病和疾病是有用的,例如肥胖症和糖尿病。
  • [EN] THERMALLY-CLEAVABLE PROTECTING AND LINKER GROUPS<br/>[FR] GROUPES PROTECTEURS ET DE LIAISON THERMIQUEMENT CLIVABLES
    申请人:EVONETIX LTD
    公开号:WO2018189546A1
    公开(公告)日:2018-10-18
    The present invention relates to chemical linkers and protecting groups, compounds and compositions containing the chemical linkers or protecting groups, and intermediates and processes that can be used to prepare them. The chemical linkers and protecting groups are based on pyrrolidine and piperidine activating groups, which undergo intramolecular cyclisation upon heating with release of carbon dioxide, thereby releasing the organic compound from a substrate. In particular, those chemical linkers and protecting groups are useful in the solid phase synthesis of oligonucleotides according to the following representative schemes.
    本发明涉及化学连接剂和保护基团,含有化学连接剂或保护基团的化合物和组合物,以及可用于制备它们的中间体和过程。这些化学连接剂和保护基团基于吡咯烷和哌哆啶活化基团,加热后发生分子内环化,并释放二氧化碳,从而释放有机化合物从底物中。特别是,这些化学连接剂和保护基团在寡核苷酸的固相合成中具有用途,具体方案如下。
  • Thermally-cleavable protecting and linker groups
    申请人:EVONETIX LTD
    公开号:US11161869B2
    公开(公告)日:2021-11-02
    The present invention relates to chemical linkers and protecting groups, compounds and compositions containing the chemical linkers or protecting groups, and intermediates and processes that can be used to prepare them. The chemical linkers and protecting groups are based on pyrrolidine and piperidine activating groups, which undergo intramolecular cyclisation upon heating with release of carbon dioxide, thereby releasing the organic compound from a substrate. In particular, those chemical linkers and protecting groups are useful in the solid phase synthesis of oligonucleotides according to the following representative schemes.
    本发明涉及化学连接体和保护基团、含有化学连接体或保护基团的化合物和组合物,以及可用于制备它们的中间体和工艺。这些化学连接剂和保护基团以吡咯烷和哌啶活化基团为基础,在加热并释放二氧化碳时,这些基团会发生分子内旋转,从而将有机化合物从底物中释放出来。这些化学连接剂和保护基团尤其适用于根据以下代表性方案进行寡核苷酸的固相合成。
  • OLIGONUCLEOTIDE AND NUCLEIC ACID SYNTHESIS
    申请人:EVONETIX LTD
    公开号:US20210047361A1
    公开(公告)日:2021-02-18
    The present invention relates to methods for the high fidelity synthesis of oligonucleotides and polynucleotides on a solid surface. In particular, the invention relates to methods of synthesising oligonucleotides, polynucleotides, and doublestranded polynucleotides/nucleic acids, such as DNA and XNA, wherein the process comprises thermally controlled deprotection steps at the 5′-OH of previously coupled nucleosides or nucleotides at selected sites on the surface of the substrate.
  • THERMALLY-CLEAVABLE PROTECTING AND LINKER GROUPS
    申请人:EVONETIX LTD
    公开号:US20210107934A1
    公开(公告)日:2021-04-15
    The present invention relates to chemical linkers and protecting groups, compounds and compositions containing the chemical linkers or protecting groups, and intermediates and processes that can be used to prepare them. The chemical linkers and protecting groups are based on pyrrolidine and piperidine activating groups, which undergo intramolecular cyclisation upon heating with release of carbon dioxide, thereby releasing the organic compound from a substrate. In particular, those chemical linkers and protecting groups are useful in the solid phase synthesis of oligonucleotides according to the following representative schemes.
查看更多

同类化合物

麦可弗汀A 六氢-2-甲基-2H-吡啶并[1,2-a]吡嗪-1,6-二酮 八氢吡啶并〔1,2-A〕吡嗪-6-酮 八氢吡啶并[1,2-a]吡嗪 八氢-吡啶并[1,2-A]吡嗪-4-酮盐酸盐 八氢-3-甲基-2H-吡啶并[1,2-a]吡嗪 八氢-2H-吡啶并[1,2-a]吡嗪-6-甲醇 7-甲氧基辛a氢-2H-吡啶并[1,2-a]吡嗪-2-胺 7-乙基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 6-甲基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 4H-吡唑[1,2-A]吡嗪-4-八氢酮 3-甲基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 2-苄基八氢-1H-吡啶并[1,2-a]吡嗪 2-硝基八氢-2H-吡啶并[1,2-a]吡嗪 2-乙基六氢-2H-吡啶并[1,2-a]吡嗪-1(6H)-酮 2-(9-甲基-3,9-二氮杂双环[3.3.1]壬-3-基)乙胺 2-(4-甲硫基唑-5-基)乙基丁酸酯 2,3,4,6,7,8,9,9alpha-八氢-1H-吡啶并[1,2-a]吡嗪-3-基甲醇 1,1'-联苯基,2-乙基-5-甲氧基- (R)-八氢吡啶并[1,2-A〕吡嗪二盐酸盐 (9aS)-八氢-4H-吡啶并[1,2-a]吡嗪-4-酮 (9aR)-八氢-2H-吡啶并[1,2-a]吡嗪 (9SS)-八氢-2-吡啶-吡嗪盐酸盐[1,2-A] (7r,9as)-八氢-2H-吡啶并[1,2-a]吡嗪-7-甲醇 (3S,6S)-3-苄基-1,4-二氮杂双环[4.4.0]癸烷-2,5-二酮 ((7S,9as)-八氢-1H-吡啶并[1,2-a]吡嗪-7-基)甲醇 ((6R,9as)-八氢-1H-吡啶并[1,2-a]吡嗪-6-基)甲醇 (S)-octahydro-2H-pyrido[1,2-a]pyrazine dihydrochloride (7R,9AS)-trans-(2,5-Difluoro-phenyl)-[7-(3-pyrrolidin-1-ylmethyl-phenoxymethyl)-octahydro-pyrido[1,2-a]pyrazin-2-yl]-methanone oxime (7RS,9ASR)-7-hydroxymethyl-2,3,4,6,7,8,9,9a-octahydro-1H-pyrido[1,2-a]pyrazine (6aα,10aα,11aα)-1,3,4,6,6a,7,8,9,10,10a,11,11a-Dodecahydro-2H-pyrazino-[1,2-b]isoquinoline-1,3-dione 17-β-cyanomarcfortine A 17-α-cyanomarcfortine A marcfortine A (trans)-benzyl 7-(8-chloroimidazo[1,5-a]pyrazin-3-yl)-4-oxohexahydro-1H-pyrido[1,2-a]pyrazine-2(6H)-carboxylate 3,5-dibromo-N-{(2S)-2-(4-fluorophenyl)-4-[3-(octahydro-2H-pyrido[1,2-a]pyrazin-2-yl)-azetidin-1-yl]butyl}-N-methylbenzamide acetate 2H-Pyrido[1,2-a]pyrazine, 2-[1-(3-fluorophenyl)ethyl]octahydro-3-methyl- 3-(4-octahydro-2H-pyrido[1,2-a]pyrazin-2-ylbutoxy)benzonitrile 1-[(7R,9aS)-2-BOC-2,3,4,6,7,8,9,9a-octahydro-1H-pyrido[1,2-a]pyrazin-7-ylmethyl]-1,3-dihydro-indol-2-one 2-<2-(3-indolyl)ethyl>-3-hydroxy-1-oxo-2,3,4,6,7,8,9,9a-octahydro-1H-pyrido<1.2-a>pyrazine 2-<2-(3-indolyl)ethyl>-1-hydroxy-3-oxo-2,3,4,6,7,8,9,9a-octahydro-1H-pyrido<1.2-a>pyrazine (1R,3R)-11,14-Dihydroxy-16-(hydroxymethyl)-13-methoxy-12,20-dimethyl-5-oxa-8,17,20-triazahexacyclo[15.3.1.03,19.04,8.09,18.010,15]henicosa-10(15),11,13-triene-21-carbonitrile trans-perhydrodiazaphenanthrene cis-perhydrodiazaphenanthrene tert-butyl (1aR,4S,6aR,7aR)-4-{[(1S,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}octahydro-5H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-5-carboxylate 2-benzyl-hexahydro-6H-pyrido[1,2-a]pyrazine-1,4-dione (7R,9aS)-2-BOC-7-(4-fluorophenoxy)methyl-2,3,4,6,7,8,9,9a-octahydro-1H-pyrido[1,2-a]pyrazine trans-7-(3-piperidin-1-ylpropoxymethyl)-octahydro-pyrido[1,2-a]pyrazine-2-carboxylic acid tert-butyl ester 2-(2-Fluoro-benzenesulfonyl)-octahydro-pyrido[1,2-a]pyrazin-6-one (3S,6R)-3-Benzyl-1,4-diazabicyclo<4.4.0>decane-2,5-dione